BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37194063)

  • 1. Coronavirus disease 2019 related parosmia: an exploratory survey of demographics and treatment strategies.
    Sowerby LJ; Almubarak Z; Biadsee A; Rocha T; Hopkins C
    J Laryngol Otol; 2023 Nov; 137(11):1256-1260. PubMed ID: 37194063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Qualitative Olfactory Dysfunction and COVID-19: An Evidence-Based Review with Recommendations for the Clinician.
    Gary JB; Gallagher L; Joseph PV; Reed D; Gudis DA; Overdevest JB
    Am J Rhinol Allergy; 2023 Jan; 37(1):95-101. PubMed ID: 35957578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Features of Parosmia Associated With COVID-19 Infection.
    Lerner DK; Garvey KL; Arrighi-Allisan AE; Filimonov A; Filip P; Shah J; Tweel B; Del Signore A; Schaberg M; Colley P; Govindaraj S; Iloreta AM
    Laryngoscope; 2022 Mar; 132(3):633-639. PubMed ID: 34870334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stellate ganglion block for treating post-COVID-19 parosmia.
    Naimi BR; Garvey E; Chandna M; Duffy A; Hunter SR; Mandloi S; Kahn C; Farquhar D; D'Souza G; Rabinowitz M; Rosen M; Toskala E; Roedl JB; Zoga A; Nyquist G; Rosen D
    Int Forum Allergy Rhinol; 2024 Jun; 14(6):1088-1096. PubMed ID: 38226898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction.
    O'Byrne L; Webster KE; MacKeith S; Philpott C; Hopkins C; Burton MJ
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013876. PubMed ID: 34291813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The outcome of olfactory impairment in patients with otherwise paucisymptomatic coronavirus disease 2019 during the pandemic.
    Jalessi M; Bagheri SH; Azad Z; Firouzabadi FD; Amini E; Alizadeh R; Chaibakhsh S; Ghalehbaghi B; Hopkins C; Farhadi M
    J Laryngol Otol; 2021 May; 135(5):426-435. PubMed ID: 33883051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and correlates of parosmia and phantosmia among smell disorders.
    Pellegrino R; Mainland JD; Kelly CE; Parker JK; Hummel T
    Chem Senses; 2021 Jan; 46():. PubMed ID: 34698820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six month follow-up of self-reported loss of smell during the COVID-19 pandemic.
    Hopkins C; Surda P; Vaira LA; Lechien JR; Safarian M; Saussez S; Kumar N
    Rhinology; 2021 Feb; 59(1):26-31. PubMed ID: 33320115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementing a COVID-19 specialist smell clinic: experience at the Wrightington, Wigan and Leigh Teaching Hospitals (WWL), NHS Foundation Trust, United Kingdom.
    Chu M; Gopikrishna D; Rocke J; Kumar BN
    Med J Malaysia; 2021 Aug; 76(Suppl 4):9-13. PubMed ID: 34558550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olfactory-related Quality of Life Adjustments in Smell Loss during the Coronavirus-19 Pandemic.
    Liu DT; Prem B; Besser G; Renner B; Mueller CA
    Am J Rhinol Allergy; 2022 Mar; 36(2):253-260. PubMed ID: 34704454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction.
    Webster KE; O'Byrne L; MacKeith S; Philpott C; Hopkins C; Burton MJ
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD013877. PubMed ID: 36063364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Validation of the Parosmia Olfactory Dysfunction Outcomes Rating (DisODOR).
    Ioerger P; Kallogjeri D; Roland L; Schneider JS; Piccirillo JF; Farrell NF
    Otolaryngol Head Neck Surg; 2023 Dec; 169(6):1654-1661. PubMed ID: 37622602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperbaric oxygen therapy for treatment of COVID-19-related parosmia: a case report.
    Krimus L; Hasan Rizvi S; Marinov A; Clarke H; Katznelson R
    Undersea Hyperb Med; 2023; 50(4):433-435. PubMed ID: 38055885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anosmia: an evolution of our understanding of its importance in COVID-19 and what questions remain to be answered.
    Saussez S; Lechien JR; Hopkins C
    Eur Arch Otorhinolaryngol; 2021 Jul; 278(7):2187-2191. PubMed ID: 32909060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified Olfactory Training Is an Effective Treatment Method for COVID-19 Induced Parosmia.
    Altundag A; Yilmaz E; Kesimli MC
    Laryngoscope; 2022 Jul; 132(7):1433-1438. PubMed ID: 35257391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distorted chemosensory perception and female sex associate with persistent smell and/or taste loss in people with SARS-CoV-2 antibodies: a community based cohort study investigating clinical course and resolution of acute smell and/or taste loss in people with and without SARS-CoV-2 antibodies in London, UK.
    Makaronidis J; Firman C; Magee CG; Mok J; Balogun N; Lechner M; Carnemolla A; Batterham RL
    BMC Infect Dis; 2021 Feb; 21(1):221. PubMed ID: 33632171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-lasting olfactory dysfunction in COVID-19 patients.
    Prem B; Liu DT; Besser G; Sharma G; Dultinger LE; Hofer SV; Matiasczyk MM; Renner B; Mueller CA
    Eur Arch Otorhinolaryngol; 2022 Jul; 279(7):3485-3492. PubMed ID: 34757458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study.
    Lechien JR; Chiesa-Estomba CM; De Siati DR; Horoi M; Le Bon SD; Rodriguez A; Dequanter D; Blecic S; El Afia F; Distinguin L; Chekkoury-Idrissi Y; Hans S; Delgado IL; Calvo-Henriquez C; Lavigne P; Falanga C; Barillari MR; Cammaroto G; Khalife M; Leich P; Souchay C; Rossi C; Journe F; Hsieh J; Edjlali M; Carlier R; Ris L; Lovato A; De Filippis C; Coppee F; Fakhry N; Ayad T; Saussez S
    Eur Arch Otorhinolaryngol; 2020 Aug; 277(8):2251-2261. PubMed ID: 32253535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-rich plasma injection in the olfactory clefts of COVID-19 patients with long-term olfactory dysfunction.
    Lechien JR; Le Bon SD; Saussez S
    Eur Arch Otorhinolaryngol; 2023 May; 280(5):2351-2358. PubMed ID: 36520209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis and Therapy of Olfactory Dysfunction - State of the ArtThe neglected sense-new evidence highlights the significance of the human sense of smell].
    Müller CA; Renner B
    Wien Med Wochenschr; 2022 Feb; 172(1-2):8-13. PubMed ID: 34851470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.